Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
15,247
datasets available to search
ShareScore release 0.9.0
Dataset results
15,247 results for “Breast cancer”
A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine
ClinicalTrials.gov study NCT06247995. IPD Sharing: YES. Countries: 13. Publications: 0.
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
ClinicalTrials.gov study NCT05535192. IPD Sharing: YES. Countries: 1. Publications: 0.
XIST Gene Deletion in Breast Cancer Therapy
ClinicalTrials.gov study NCT04093609. IPD Sharing: UNDECIDED. Countries: 0. Publications: 5.
Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation Therapy
ClinicalTrials.gov study NCT02422498. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Patterns of Relapse After Neoadjuvant Chemotherapy in Breast Cancer
ClinicalTrials.gov study NCT06210347. IPD Sharing: Not stated. Countries: 0. Publications: 8.
Study to Evaluate the Efficacy and Safety of Eribulin Mesylate Administered Biweekly (Q2W) for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT02481050. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT00121836. IPD Sharing: Not stated. Countries: 1. Publications: 0.
XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer
ClinicalTrials.gov study NCT00127933. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of LY2523355 in Participants With Breast Cancer
ClinicalTrials.gov study NCT01416389. IPD Sharing: YES. Countries: 1. Publications: 0.
Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer
ClinicalTrials.gov study NCT00376805. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer
ClinicalTrials.gov study NCT00331552. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast Cancer
ClinicalTrials.gov study NCT00442260. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Avastin (Bevacizumab) in Combination With Taxane-based Chemotherapy as First Line Treatment in Patients With HER-2 Negative Breast Cancer
ClinicalTrials.gov study NCT00846027. IPD Sharing: Not stated. Countries: 1. Publications: 0.
S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer
ClinicalTrials.gov study NCT00005975. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening
ClinicalTrials.gov study NCT03482557. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Panobinostat Monotherapy in Women With HER2-negative Locally Recurrent or Metastatic Breast Cancer
ClinicalTrials.gov study NCT00777049. IPD Sharing: NO. Countries: 1. Publications: 0.
LY3023414 and Prexasertib in Metastatic Triple-negative Breast Cancer
ClinicalTrials.gov study NCT04032080. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Perjeta (Pertuzumab) in Combination With Herceptin (Trastuzumab) in Participants With Metastatic Breast Cancer
ClinicalTrials.gov study NCT01674062. IPD Sharing: Not stated. Countries: 5. Publications: 0.
L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients
ClinicalTrials.gov study NCT02834403. IPD Sharing: NO. Countries: 1. Publications: 0.
Durvalumab with Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer
ClinicalTrials.gov study NCT03820141. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.